| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.37 | 2e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.29 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.081 | 0.2 |